GEODE CAPITAL MANAGEMENT, LLC - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 79 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,333,580
-1.0%
1,182,110
+12.2%
0.00%0.0%
Q2 2023$27,614,021
+29.5%
1,053,166
+27.1%
0.00%0.0%
Q1 2023$21,324,517
+102411.9%
828,458
+3.6%
0.00%0.0%
Q4 2022$20,802
-99.9%
799,779
+29.2%
0.00%0.0%
Q3 2022$17,657,000
+28.6%
618,894
+11.0%
0.00%
+50.0%
Q2 2022$13,729,000
-52.6%
557,664
+8.6%
0.00%
-50.0%
Q1 2022$28,971,000
-5.1%
513,308
+4.3%
0.00%0.0%
Q4 2021$30,515,000
-1.3%
492,338
+1.0%
0.00%0.0%
Q3 2021$30,922,000
-25.5%
487,436
-3.2%
0.00%
-33.3%
Q2 2021$41,499,000
+25.9%
503,569
+12.4%
0.01%
+20.0%
Q1 2021$32,969,000
+12.0%
448,134
+10.4%
0.01%0.0%
Q4 2020$29,429,000
+82.7%
405,811
+20.1%
0.01%
+66.7%
Q3 2020$16,106,000
+61.7%
337,874
+42.4%
0.00%
+50.0%
Q2 2020$9,963,000
+129.8%
237,224
+47.7%
0.00%
+100.0%
Q1 2020$4,336,000
-57.2%
160,613
-39.0%
0.00%0.0%
Q4 2019$10,130,000263,1940.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$480,558,00031.49%
Consonance Capital Management LP 1,199,339$98,838,00011.90%
Boxer Capital, LLC 2,075,905$171,075,0006.04%
Perceptive Advisors 9,699,824$799,362,0005.19%
Orbimed Advisors 6,044,266$498,108,0005.04%
Samsara BioCapital, LLC 169,852$13,998,0001.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,375,775$113,378,0001.50%
SPHERA FUNDS MANAGEMENT LTD. 195,117$16,080,0001.09%
Artal Group S.A. 500,000$41,205,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$46,032,0000.82%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders